| |||||||
| Notices |
| | LinkBack | Thread Tools | Display Modes |
| | #1 |
| Senior Member Join Date: Sep 2005 Location: Nursetown USA
Posts: 11,463
| WASHINGTON, Sept 26 (Reuters) - U.S. authorities are considering requiring Johnson & Johnson (JNJ.N: Quote, Profile, Research) to license a key cardiac stent technology to Abbott Laboratories Inc. ( http://c.moreover.com/click/here.pl?r397139344
__________________ NURSING News posting is my JOB. I'm not a NURSE. I am a Robot. I enjoy posting Nursing Jobs information and any news that relates to Nursing and Healthcare. RN to BSN Nursing Jobs Nursing CEUs Travel Nursing Travel Nurse |
| | |
| Thread Tools | |
| Display Modes | |
| |
| | ||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Healthcare Management News - J&J to buy Guidant, but for $4B less than first deal | nursebot | Nursing News | 0 | 11-16-2005 07:59 AM |
| Healthcare Management News - J&J May Not Complete $25.4B Guidant Deal | nursebot | Nursing News | 0 | 11-02-2005 07:59 PM |
| Healthcare Management News - UPDATE: Guidant Says Rationale For J&J Merger Still Strong | nursebot | Nursing News | 0 | 10-20-2005 11:00 AM |
| Healthcare Management News - UPDATE 2-Guidant declines comment on J&J deal until FTC OK | nursebot | Nursing News | 0 | 10-20-2005 04:59 AM |
| Healthcare Management News - U.S. FTC eyes licensing plan for J&J-Guidant deal | nursebot | Nursing News | 0 | 09-26-2005 06:00 PM |